Can regenerative medicine save Big Pharma&#x2019;s business model from the patent cliff?
Denoon
Alexander
A
Vollebregt
Erik
E
D003132:Commerce; D010330:Patents as Topic; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence / Q000379:methods*